Turning Point Therapeutics Inc (TPTX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
76.01 +0.52 (+0.69%) 08/16/22 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 76.01 unch (unch) -
for Tue, Aug 16th, 2022
Results
download Want to compare other data? Select Fields| Symbol | TPTX | IONS | SLNO | ||
| Company | Turning Point Therapeutics Inc | Ionis Pharmaceuticals | Soleno Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 75.99 | 28.31 | 69.96 | ||
| High | 76.01 | 28.76 | 70.51 | ||
| Low | 75.98 | 28.04 | 68.34 | ||
| Last | 76.01 | 28.40 | 69.98 | ||
| Change | +0.52 | +0.05 | +0.05 | ||
| % Change | +0.69% | +0.18% | +0.07% | ||
| Volume | 2,843,300 | 842,600 | 1,236,200 | ||
| 20-Day Average Volume | 962,475 | 1,981,665 | 2,600,915 | ||
| Previous Close | 75.49 | 28.35 | 69.93 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 75.11 | 29.20 | 64.64 | ||
| 20-Day Raw Stochastic | 100.00% | 45.36% | 84.98% | ||
| 20-Day Relative Strength | 74.20% | 43.93% | 61.96% | ||
| Weighted Alpha | -18.70 | -35.74 | +49.41 | ||
| Today's Opinion | 96% Buy | 100% Sell | 100% Buy | ||
| Previous Opinion | 96% Buy | 100% Sell | 100% Buy | ||
| Last Month's Opinion | 88% Buy | 40% Sell | 32% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.29% since 08/09/22 | +6.33% since 04/10/25 | +11.31% since 04/10/25 | ||
| Low | 74.86 on 08/10/22 | 26.30 on 04/11/25 | 62.11 on 04/11/25 | ||
| High | 76.01 on 08/16/22 | 29.04 on 04/14/25 | 71.00 on 04/16/25 | ||
| 1-Month | |||||
| %Chg | +1.82% since 07/15/22 | -17.20% since 03/17/25 | +41.00% since 03/17/25 | ||
| Low | 74.57 on 07/21/22 | 23.95 on 04/09/25 | 47.23 on 03/21/25 | ||
| High | 76.01 on 08/16/22 | 34.13 on 03/18/25 | 74.00 on 04/03/25 | ||
| 3-Month | |||||
| %Chg | +134.02% since 05/16/22 | -9.64% since 01/17/25 | +49.27% since 01/17/25 | ||
| Low | 30.85 on 05/25/22 | 23.95 on 04/09/25 | 43.00 on 03/11/25 | ||
| High | 76.01 on 08/16/22 | 35.31 on 01/27/25 | 74.00 on 04/03/25 | ||
| 6-Month | |||||
| %Chg | +124.48% since 02/16/22 | -26.21% since 10/17/24 | +30.80% since 10/17/24 | ||
| Low | 23.77 on 03/15/22 | 23.95 on 04/09/25 | 41.50 on 01/15/25 | ||
| High | 76.01 on 08/16/22 | 40.58 on 10/29/24 | 74.00 on 04/03/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,806,125 | 4,514,606 | 3,209,073 | ||
| Shares Outstanding, K | 50,074 | 158,965 | 45,857 | ||
| Annual Sales | 30,830,000 | 705,140,000 | 0 | ||
| Annual Net Income | -236,550,000 | -453,900,000 | -175,850,000 | ||
| Last Quarter Sales | 120,000 | 226,580,000 | 0 | ||
| Last Quarter Net Income | -123,090,000 | -104,350,000 | -55,980,000 | ||
| 60-Month Beta | -0.18 | 0.29 | -2.29 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.48 on 08/08/22 | -0.66 on 02/19/25 | -1.27 on 02/27/25 | ||
| Latest Earnings Date | 08/08/22 | 04/30/25 | 05/08/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||